Algorae Pharmaceuticals Ltd - Company Profile

Powered by

All the sales intelligence you need on Algorae Pharmaceuticals Ltd in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Algorae Pharmaceuticals Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Algorae Pharmaceuticals Ltd.

Back to companies

Algorae Pharmaceuticals Ltd: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Algorae Pharmaceuticals Ltd patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
RU2017143158A Application Лечение заболевания цнс с помощью инкапсулированных индуцируемых клеток сосудистого сплетения C12N5/0012; C12N5/0622; A61K2035/128; A61K2300/00; A61K31/05; A61K31/185; A61K31/355; A61K31/375; A61K31/575; A61K31/593; A61K31/662; A61K33/00; A61K33/14; A61K35/30; A61K38/063; A61K38/193; A61K45/06; A61K9/0085; A61K9/48; A61K9/5031; A61K9/5036; A61P25/00; A61P25/28 June 17, 2019
WO2019089993A1 Application Pericyte protective agents for neurological disorders including neurodegenerative diseases, central nervous system diseases and others G01N33/5058; A61K35/30; G01N33/5044; C12N5/069; A61K2035/128 May 09, 2019
EP3294274A4 Search Report Behandlung von krankheiten des zentralnervensystems mit verkapseltem induzierbaren plexus-choroideus-zellen C12N5/0012; C12N5/0622; A61K2035/128; A61K2300/00; A61K31/05; A61K31/185; A61K31/355; A61K31/375; A61K31/575; A61K31/593; A61K31/662; A61K33/00; A61K33/14; A61K35/30; A61K38/063; A61K38/193; A61K45/06; A61K9/0085; A61K9/48; A61K9/5031; A61K9/5036; A61P25/00; A61P25/28 February 13, 2019
MX2017014442A Application Treatment of cns disease with encapsulated inducible choroid plexus cells. A61K2035/128; A61K2300/00; A61K31/05; A61K31/185; A61K31/355; A61K31/375; A61K31/575; A61K31/593; A61K31/662; A61K33/00; A61K33/14; A61K35/30; A61K38/063; A61K38/193; A61K45/06; A61K9/0085; A61K9/48; A61K9/5031; A61K9/5036; A61P25/00; A61P25/28; C12N5/0012; C12N5/0622 August 01, 2018
BR112017024509A2 Application tratamento de doença do cns com células de plexo coroide induzíveis encapsulada C12N5/0012; C12N5/0622; A61K2035/128; A61K2300/00; A61K31/05; A61K31/185; A61K31/355; A61K31/375; A61K31/575; A61K31/593; A61K31/662; A61K33/00; A61K33/14; A61K35/30; A61K38/063; A61K38/193; A61K45/06; A61K9/0085; A61K9/48; A61K9/5031; A61K9/5036; A61P25/00; A61P25/28 July 24, 2018
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer